Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Journal of Immunological Methods|February 23, 2013
Estimating the ratio of CD4+ to CD8+ T cells using high-throughput sequence dataRyan Emerson, Anna Sherwood, Cindy Desmarais, et al.Genes & Development|December 3, 2014
The evolution of thymic lymphomas in p53 knockout miceCrissy Dudgeon, Chang Chan, Wenfeng Kang, et al.Antibody Therapeutics|June 30, 2022
Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variantsEmily Engelhart, Randolph Lopez, Ryan Emerson, et al.Journal of Clinical Pathology|April 12, 2018
Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphomaBryan Rea, Paul Haun, Ryan Emerson, et al.Scientific Data|October 26, 2022
A dataset comprised of binding interactions for 104,972 antibodies against a SARS-CoV-2 peptideEmily Engelhart, Ryan Emerson, Leslie Shing, et al.Oncoimmunology|August 2, 2014
Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytesLidia Robert, Christina Harview, Ryan Emerson, et al.Journal of Neuro-Oncology|January 12, 2018
Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell responseAshley S Plant, Shohei Koyama, Claire Sinai, et al.Science Immunology|April 4, 2017
Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8+ T Cells In VivoAude G Chapuis, Cindy Desmarais, Ryan Emerson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
CTLA4 blockade broadens the peripheral T-cell receptor repertoireLidia Robert, Jennifer Tsoi, Xiaoyan Wang, et al.Clinical Breast Cancer|April 5, 2018
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive PhenotypeJeremy Force, Lynn J Howie, Sara E Abbott, et al.Pageof 2